Gabexate Mesilate Suppresses Influenza Pneumonia in Mice through Inhibition of Cytokines

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of International Medical Research

• Publication date

  2008-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/147323000803600215PMID 18380943
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents.

  2007cited by this paper
• Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study.

  2007cited by this paper
• Synthetic serine protease inhibitor, gabexate mesilate, prevents nuclear factor-kappaB activation and increases TNF-alpha-mediated apoptosis in human pancreatic cancer cells.

  2007cited by this paper
• Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

  2007cited by this paper
• Synthetic Serine Protease Inhibitor, Gabexate Mesilate, Prevents Nuclear Factor-κB Activation and Increases TNF-α-Mediated Apoptosis in Human Pancreatic Cancer Cells

  2007cited by this paper
• Effects of gabexate mesilate on serum inflammatory cytokines in rats with acute necrotizing pancreatitis.

  2006cited by this paper
• Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus.

  2005cited by this paper
• Guidelines for the management of adult lower respiratory tract infections

  2005cited by this paper
• Effect of synthetic protease inhibitor gabexate mesilate on the attenuation of ischemia/reperfusion injury in canine kidney autotransplantation.

  2005cited by this paper
• Cooperative anti-influenza activities of respiratory innate immune proteins and neuraminidase inhibitor.

  2005cited by this paper
• Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice

  2004cited by this paper
• Acute infection with influenza virus enhances susceptibility to fatal pneumonia following Streptococcus pneumoniae infection in mice with chronic pulmonary colonization with Pseudomonas aeruginosa

  2004cited by this paper
• Efficacy of gabexate mesilate on disseminated intravascular coagulation as a complication of infection developing after abdominal surgery.

  2004cited by this paper
• Protective effects of inhaled nitric oxide and gabexate mesilate in lung reperfusion injury after transplantation from non-heart-beat donors.

  2002cited by this paper
• Impact of respiratory virus infections on persons with chronic underlying conditions.

  2000cited by this paper
• Principles and Practice of Clinical Virology

  1999cited by this paper
• Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation.

  1999cited by this paper
• Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity

  1992cited by this paper
• Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein.

  1992cited by this paper
• Clinical trial with a protease inhibitor gabexate mesilate in acute pancreatitis

  1991cited by this paper

• Bioinformatics Approach Predicts Candidate Targets for SARS-CoV-2 Infections to COPD Patients

  2022cites this paper
• The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment

  2022cites this paper
• The discovery and development of transmembrane serine protease 2 (TMPRSS2) inhibitors as candidate drugs for the treatment of COVID-19

  2022cites this paper
• The clinically used serine protease inhibitor nafamostat reduces influenza virus replication and cytokine production in human airway epithelial cells and viral replication in mice

  2020cites this paper
• Virulent Pseudorabies Virus Infection Induces a Specific and Lethal Systemic Inflammatory Response in Mice

  2018cites this paper
• Suppression of interleukin-6 increases enterovirus A71 lethality in mice

  2017cites this paper
• The Role of Neutrophil Extracellular Traps in Infectious Diseases

  2017cites this paper
• Immunology Causes , Clinical Symptoms , Virology , and Respiratory Viral Infections in Infants :

  2017cites this paper
• A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy

  2017cites this paper
• Serine Proteases and their Inhibitors in Human Airway Epithelial Cells: Effectson Influenza Virus Replication and Airway Serine Proteases and their Inhibitors in Human Airway Epithelial Cells: Effects on Influenza Virus Replication and Airway Inflammation

  2016influential citation
• The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells

  2015cites this paper
• This information is current as Pneumoniain Murine Influenza Chemokine-Dependent Deleterious Kinase-M in Regulating Critical Role of IL-1 Receptor-Associated

  2013cites this paper
• Newer influenza antivirals, biotherapeutics and combinations

  2013cites this paper
• Mechanisms of Increased Severity of Influenza-Related Pneumonia

  2013cites this paper
• ImmunologyClinical Symptoms, Virology, and Respiratory Viral Infections in Infants:

  2013cites this paper
• Effect of synthetic protease inhibitor gabexate mesilate on attenuation of coagulant activity and cytokine release in a rat model of islet transplantation.

  2011cites this paper
• Sustained High Levels of Interleukin-6 Contribute to the Pathogenesis of Enterovirus 71 in a Neonate Mouse Model

  2011cites this paper
• Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology

  2010cites this paper
• [Mechanisms and theraupeutic analysis for severe influenza-related pneumonia].

  2010cites this paper
• This information is current as Pneumonia Inflammation in Murine Influenza Chemokine-Dependent Deleterious Kinase-M in Regulating Critical Role of IL-1 Receptor-Associated

  2010influential citation
• Critical Role of IL-1 Receptor-Associated Kinase-M in Regulating Chemokine-Dependent Deleterious Inflammation in Murine Influenza Pneumonia

  2009influential citation
• A patient with fulminant influenza-related bacterial pneumonia due to Streptococcus pneumoniae followed by Mycobacterium tuberculosis infection.

  2008cites this paper